3,4-Difluorobenzyl Bromide | CAS:85118-01-0

We serve 3,4-Difluorobenzyl Bromide CAS:85118-01-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3,4-Difluorobenzyl Bromide

Chemical Name:3,4-Difluorobenzyl Bromide
CAS.NO:85118-01-0
Synonyms:alpha-Bromo-3,4-difluorotoluene;
3,4-Difluoro Bromine Benzyl;
Molecular Formula:C7H5BrF2
Molecular Weight:207.01500
 
Physical and Chemical Properties:
Density:1.618;
Boiling point:59-61oC;
Flash point:175oF;
Index of Refraction:1.526;
 
Specification:
Appearance:Off-white to white powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 3,4-Difluorobenzyl Bromide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,4-Difluoro Bromine Benzyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4-Difluorobenzyl Bromide Use and application,3,4-Difluorobenzyl Bromide technical grade,usp/ep/jp grade.


Related News: The first is the API – which is the central ingredient.4,4,5,5,5-Pentafluoro-1-pentanol manufacturer Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate supplier Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.Methanesulfonamide vendor Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.